LAB vs PGR · rev $174.4M vs P/E 10, rev $87.67B
Standard Biotools Inc (LAB) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
LAB currently screens at market cap $317.1M. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the LAB and PGR stock pages for the full models.
Not investment advice.